Clinical presentation and renal evaluation of human visceral Leishmaniasis (Kala-azar): A retrospective study of 57 patients in Brazil

Brazilian Journal of Infectious Diseases

Volumn 12, Issue 4, 2008, Pages 329-332

  Daher, Elizabeth Francesco ^a,b   Evangelista, Leandro F ^a   Silva Júnior, Geraldo B ^a   Lima, Rafael S A ^a   Aragão, Eveline B ^a   Arruda, Germana A J C ^a   Galeano, Noemi M F ^a   Mota, Rosa M S ^a   Oliveira, Rodrigo A ^a   Silva, Sônia L ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b NONE   (Brazil)

Author keywords

Acute renal failure; Kala azar; Symptoms; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; CREATININE;

ACUTE KIDNEY FAILURE; ADULT; ANOREXIA; ARTICLE; ASTHENIA; BRAZIL; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; FEVER; HEPATOMEGALY; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PALLOR; RETROSPECTIVE STUDY; SPLENOMEGALY; VISCERAL LEISHMANIASIS; VOMITING; WEIGHT REDUCTION;

EID: 60649102498     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702008000400015     Document Type: Article

References (18)

1. Herwaldt B.L. Leishmaniasis. Lancet 1999;354:1191-9.
2. Badaró R., Duarte M.I.S. Leishmaniose visceral (Calazar). In Veronesi R., Focaccia R. eds. Tratado de Infectologia. São Paulo (Brazil): Atheneu, 2002.
3. Efstratiadis G., Boura E., Giamalis P. et al. Renal involvement in a patient with visceral leishmaniasis. Nephrol Dial Transplant 2006; 21:235-6.
4. Guerin P.J., Olliaro P., Sundar S., et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002;2:494-501.
5. Camargo L.B., Langoni H. Impact of leishmaniasis on public health. Journal of Venomon Animals and Toxins including Tropical Diseases 2006;12:527-48.
6. Dantas-Torres F., Brandão-Filho S.P. Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control. Rev Inst Med Trop São Paulo 2006;48:151-6.
7. Boakye D.A., Wilson M.D., Kweku M. A review of leishmaniasis in West Africa. Ghana Med J 2005;39:94-7.
8. Salgado Filho N., Ferreira T.M.A.F., Costa J.M.L. Involvement of the renal function in patients with visceral leishmaniasis (kala-azar). Rev Soc Bras Med Trop 2003;36:217-21.
9. Pastorinho A.C., Jacob C.M.A., Oselka G.W., Carneiro-Sampaio M.M.S. Visceral leishmaniasis: clinical and laboratorial aspects. J Pediatr (Rio J) 2002;78:120-7.
10. Gontijo C.M.F. Visceral leishmaniasis in Brazil: current status, challenges and prospects. Revista Brasileira de Epidemiologia 2004;7:338-49.
11. Olliaro P.L., Guerin P.J., Gerstl S., et al. Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis 2005;5:763-74.
12. Pedrosa C.M.S., Rocha E.M.M. Clinical and epidemiological aspects of visceral leishmaniasis in children up to 15 years of age in Alagoas, Brazil. Rev Soc Bras Med Trop 2004;37:300-4.
13. Silva E.S., Gontijo C.M.F., Pacheco R.S., et al. Visceral leishmaniasis in the metropolitan region of Belo Horizonte, State of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 2001;96:285-91.
14. Carmona Espinazo F.F., Espigares Jiménez M., Mangas Rojas A., Biedma Alvarez D. Visceral leishmaniasis in an immunocompetent patient: an entity to be considered in the differential diagnosis of fever of unknown origin. An Med Interna (Madrid) 2004;21:466.
15. Lima Verde F.A.A., Lima Verde F.A., Lima Verde I.A., et al. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study of 50 patients from Brazil. J Nephrol 2007; 20:430-6.
16. Navarro M., Bonet J., Bonal J., Romero R. Secondary amyloidosis with irreversible acute renal failure caused by visceral leishmaniasis in a patient with AIDS. Nefrologia 2006;26:745-6.
17. Bagnis C.I., Deray G. Amphotericin B nephrotoxicity. Saudi J Kidney Dis Transpl 2002;13:481-91.
18. Berdichevski R.H., Luis L.B., Crestana L., Manfro R.C. Amphotericin B-related nephrotoxicity in low risk patients. Braz J Infect Dis 2006;10:94-9.